Growth Metrics

Sonoma Pharmaceuticals (SNOA) Operating Margin: 2010-2012

Historic Operating Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -19.21%.

  • Sonoma Pharmaceuticals' Operating Margin rose 6516.00% to -19.21% in Q4 2012 from the same period last year, while for Dec 2012 it was -22.35%, marking a year-over-year increase of 3043.00%. This contributed to the annual value of -50.75% for FY2012, which is 2620.00% up from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Operating Margin of -19.21% as of Q4 2012, which was down 6.41% from -18.05% recorded in Q3 2012.
  • Sonoma Pharmaceuticals' 5-year Operating Margin high stood at -12.22% for Q2 2012, and its period low was -105.83% during Q2 2010.
  • In the last 3 years, Sonoma Pharmaceuticals' Operating Margin had a median value of -51.13% in 2011 and averaged -52.45%.
  • Examining YoY changes over the last 5 years, Sonoma Pharmaceuticals' Operating Margin showed a top increase of 6,516bps in 2012 and a maximum decrease of 85bps in 2012.
  • Over the past 3 years, Sonoma Pharmaceuticals' Operating Margin (Quarterly) stood at -89.84% in 2010, then skyrocketed by 547bps to -84.37% in 2011, then spiked by 6,516bps to -19.21% in 2012.
  • Its last three reported values are -19.21% in Q4 2012, -18.05% for Q3 2012, and -12.22% during Q2 2012.